WallStreetZen

NYSE: BMY
Bristol Myers Squibb Co Stock Forecast, Predictions & Price Target

Analyst price target for BMY

Based on 5 analysts offering 12 month price targets for Bristol Myers Squibb Co.
Min Forecast
$62.00+7.64%
Avg Forecast
$69.20+20.14%
Max Forecast
$76.00+31.94%

Should I buy or sell BMY stock?

Based on 5 analysts offering ratings for Bristol Myers Squibb Co.
Buy
Strong Buy
2 analysts 40%
Buy
0 analysts 0%
Hold
3 analysts 60%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

BMY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Morgan Stanley
Top 15%
86
HoldMaintains$66.00+14.58%2021-10-12
Anonymous
Berenberg
Strong BuyMaintains$71.00+23.26%2021-10-11
Barclays
Bottom 17%
17
HoldMaintains$68.00+18.06%2021-10-08
Morgan Stanley
Top 28%
73
HoldDowngrades$62.00+7.64%2021-04-30
Truist Securities
Top 25%
76
Strong BuyUpgrades$74.00+28.47%2021-04-13
Societe Generale
Bottom 27%
27
Strong BuyUpgrades$76.00+31.94%2020-11-16

1 of 1

Forecast return on equity

Is BMY forecast to generate an efficient return?
Company
52.82%
Industry
75.11%
Market
17.3%
BMY's Return on Equity is forecast to be high in 3 years (52.82%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is BMY forecast to generate an efficient return on assets?
Company
17.55%
Industry
16.47%
BMY is forecast to generate higher Return on Assets (17.55%) than the US Drug Manufacturers - General industry average (16.47%)
Forecast

BMY earnings per share forecast

What is BMY's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$7.46-433.04%
Avg 2 year Forecast
$8.04-458.93%
Avg 3 year Forecast
$8.53-480.8%

BMY revenue forecast

What is BMY's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$46.3B+4.35%
Avg 2 year Forecast
$48.0B+8.08%
Avg 3 year Forecast
$49.5B+11.53%
BMY's revenue is forecast to grow at a rate of 3.7% per year, which is not exceptional
Forecast

BMY revenue growth forecast

How is BMY forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
3.7%
Industry
4.71%
Market
11.79%
BMY's revenues are forecast to grow slower (3.7% per year) than the US Drug Manufacturers - General industry average (4.71%)
Forecast
BMY's revenues are forecast to grow slower (3.7% per year) than the US market average (11.79%)
Forecast

Bristol Myers Squibb Stock Forecast FAQ

Is Bristol Myers Squibb Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NYSE: BMY) stock is to Buy BMY stock.

Out of 5 analysts, 2 (40%) are recommending BMY as a Strong Buy, 0 (0%) are recommending BMY as a Buy, 3 (60%) are recommending BMY as a Hold, 0 (0%) are recommending BMY as a Sell, and 0 (0%) are recommending BMY as a Strong Sell.

What is BMY's earnings growth forecast for 2021-2023?

(NYSE: BMY) Bristol Myers Squibb's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 22.55%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.31%.

Bristol Myers Squibb's earnings in 2021 is -$5,079,000,000.On average, 7 Wall Street analysts forecast BMY's earnings for 2021 to be $16,576,967,105, with the lowest BMY earnings forecast at $16,332,534,615, and the highest BMY earnings forecast at $16,776,957,325. On average, 8 Wall Street analysts forecast BMY's earnings for 2022 to be $17,865,792,966, with the lowest BMY earnings forecast at $17,443,591,391, and the highest BMY earnings forecast at $18,621,311,574.

In 2023, BMY is forecast to generate $18,954,628,607 in earnings, with the lowest earnings forecast at $18,065,783,186 and the highest earnings forecast at $20,110,127,655.

What is BMY's revenue growth forecast for 2021-2023?

(NYSE: BMY) Bristol Myers Squibb's forecast annual revenue growth rate of 3.7% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 4.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.79%.

Bristol Myers Squibb's revenue in 2021 is $44,384,000,000.On average, 5 Wall Street analysts forecast BMY's revenue for 2021 to be $102,920,589,040,931, with the lowest BMY revenue forecast at $102,767,418,753,723, and the highest BMY revenue forecast at $103,101,624,632,094. On average, 5 Wall Street analysts forecast BMY's revenue for 2022 to be $106,599,835,779,402, with the lowest BMY revenue forecast at $104,210,303,747,092, and the highest BMY revenue forecast at $109,805,963,432,850.

In 2023, BMY is forecast to generate $109,997,087,419,544 in revenue, with the lowest revenue forecast at $107,536,963,283,882 and the highest revenue forecast at $114,106,197,580,616.

What is BMY's forecast return on assets (ROA) for 2021-2024?

(NYSE: BMY) forecast ROA is 17.55%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.47%.

What is BMY's Price Target?

According to 5 Wall Street analysts that have issued a 1 year BMY price target, the average BMY price target is $69.20, with the highest BMY stock price forecast at $76.00 and the lowest BMY stock price forecast at $62.00.

On average, Wall Street analysts predict that Bristol Myers Squibb's share price could stay at $69.20 by Oct 12, 2022. The average Bristol Myers Squibb stock price prediction forecasts a potential downside of N/A from the current BMY share price of $57.60.

What is BMY's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: BMY) Bristol Myers Squibb's current Earnings Per Share (EPS) is -$2.24. On average, analysts forecast that BMY's EPS will be $7.46 for 2021, with the lowest EPS forecast at $7.35, and the highest EPS forecast at $7.55. On average, analysts forecast that BMY's EPS will be $8.04 for 2022, with the lowest EPS forecast at $7.85, and the highest EPS forecast at $8.38. In 2023, BMY's EPS is forecast to hit $8.53 (min: $8.13, max: $9.05).

What is BMY's forecast return on equity (ROE) for 2021-2024?

(NYSE: BMY) forecast ROE is 52.82%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.